Logo der Universitätsmedizin Mainz
IMBEI
Institut für Medizinische Biometrie,
Epidemiologie und Informatik

 

PD Dr. Antje Jahn

Susanne Singer

Gebäude 902
1. Etage, Raum 117

Tel 06131 17-8246
Fax 06131 17-2968
Mail antje.jahn@unimedizin-mainz.de

 

 

 

Funktion

stellvertretende Leitung der Abteilung Medizinische Biometrie

Wissenschaftliche Schwerpunkte

Klinische Studien
Adaptive Studiendesigns
Überlebenszeitanalysen



Aktuelle Projekte

Methodische Publikationen

  • Ingel K, Jahn-Eimermacher A (2014). Sample size calculation and reestimation for a semiparametric analysis of recurrent event data taking robust standard errors into account. Biometrical Journal 56, 631-48.
  • Rauch G, Jahn-Eimermacher A, Brannath W, Kieser M (2013). Opportunities and challenges of combined effect measures based on prioritized outcomes. Statistics in Medicine 33, 1104-1120.
  • Jahn-Eimermacher A, Robinson J, Quanbeck A, McCarty D (2012): Sample size calculation for survival time data in cluster randomized trials using NIATx 200 as an example. Proceedings of the Joint Statistical Meeting, 90-97.
  • Jahn-Eimermacher A, Ingel K, Schneider A (2012): Sample size in cluster randomized trials with a time to event as the primary outcome. Statistics in Medicine 32, 739-51.
  • Jahn-Eimermacher A, Lasarzik I, Raber J (2011): Statistical analysis of latency outcomes in behavioral experiments. Behav Brain Res. 221(1), 271-5.
  • Jahn-Eimermacher A, Ingel K 2009: Adaptive trial design: A general methodology for censored time to event data. Contemp Clin Trials 30(2), 171-7.
  • Jahn-Eimermacher A, 2008: A comparison of the generalized Cox model based on independent increments with poisson and negative binomial regression models on simulated and real recurrent failure time data. Computational Statistics and Data Analysis 52, 4989-97.
  • Jahn-Eimermacher A, duPrel JB, Schmitt HJ, 2007: Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children. A methodological overview of statistical practice in randomized controlled clinical trials. Vaccine 25(33), 6237-44.
  • Jahn-Eimermacher A, Hommel G, 2007: Performance of adaptive sample size adjustment with respect to stopping criteria and time of interim analysis. Statistics in Medicine 26, 1450-61.

Medizinische Publikationen

  • Rey JW, Jahn-Eimermacher A, Doernberger V, Barreiros AP, Krupp M, Hoffman A, Kiesslich R, Müller-Schilling M, Galle PR, Teufel A (2014). To biopsy or not to biopsy: evaluation of a large german cohort of patients with abnormal liver tests of unknown etiology. Digestion 89, 310-8.
  • Schaible EV, Steinsträßer A, Jahn-Eimermacher A, Luh C, Sebastiani A, Kornes F, Pieter D, Schäfer MK, Engelhard K, Thal SC (2013). Single administration of tripeptide α-MSH(11-13) attenuates brain damage by reduced inflammation and apoptosis after experimental traumatic brain injury in mice. PLoS One; 8:e71056.
  • Brückner M, Lasarzik I, Jahn-Eimermacher A, Peetz D, Werner C, Engelhard K, Thal SC (2013). High dose infusion of activated protein C (rhAPC) fails to improve neuronal damage and cognitive deficit after global cerebral ischemia in rats. Neuroscience Letter 551, 28-33.
  • Mordhorst C, Latz B, Kerz T, Wisser G, Schmidt A, Schneider A, Jahn-Eimermacher A, Werner C, Engelhard K (2010). Prospective assessment of postoperative pain after craniotomy. Journal of Neurosurgical Anesthesiology 22, 202-6.
  • Koch FP, Weng D, Krämer S, Biesterfeld S, Jahn-Eimermacher A, Wagner W (2010). Osseointegration of one-piece zirconia implants compared with a titanium implant of identical design: a histomorphometric study in the dog. Clinical Oral Implants Research 21, 350-6.
  • Moergel M, Jahn-Eimermacher A, Krummenauer F, Reichert TE, Wagner W, Wendt TG, Werner JA, Al-Nawas B (2009). Effectiveness of adjuvant radiotherapy in patients with oropharyngeal and floor of mouth squamous cell carcinoma and concomitant histological verification of singular ipsilateral cervical lymph node metastasis (pN1-state)--a prospective multicenter randomized controlled clinical trial using a comprehensive cohort design. Trials 10, 118.
  • Lasarzik I, Winkelheide U, Thal SC, Benz N, Lörscher M, Jahn-Eimermacher A, Werner C, Engelhard K (2009). Mild hypothermia has no long-term impact on postischemic neurogenesis in rats. Anesthesia & Analgesia 109, 1632-9.
  • Huebner G, Link H, Kohne CH, Stahl M, Kretzschmar A, Steinbach S, Folprecht G, Bernhard H, Al-Batran SE, Schoffski P, Burkart C, Kullmann F, Otremba B, Menges M, Hoffmann M, Kaiser U, Aldaoud A, Jahn A (2009); German CUP Study Group. Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial. British Journal of Cancer 100,44-9.
  • Moehler M, Eimermacher A, Siebler J, Höhler T, Wein A, Menges M, Flieger D, Junginger T, Geer T, Gracien E, Galle PR, Heike M (2005). Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer. British Journal of Cancer 92, 2122-8.
  • Schlitt A, von Bardeleben RS, Ehrlich A, Eimermacher A, Peetz D, Dahm M, Rupprecht HJ (2003). Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement (CAPTA). Thrombosis Research 109, 131-5.